News
Pfizer’s Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment...
Pfizer Inc announced today that the Japanese Ministry of Health, Labour and Welfare approved Lyrica® (pregabalin) capsules for the treatment of peripheral neuropathic...
News
PRADAX gains approval in Canada for stroke prevention in...
Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), 1 Boehringer Ingelheim’s novel, oral direct thrombin inhibitor 2 for the prevention of stroke...
News
Significant Milestone for Tengion Clinical Program Currently Enrolling Bladder...
Tengion, Inc., a leader in regenerative medicine, announced that surgeons at the University of Chicago have implanted its Neo-Urinary Conduit(TM) in the first patient as...
News
AstraZeneca initiates phase IIB study for AZD9773 (CytoFab) as...
AstraZeneca announced that it has commenced dosing patients in a global Phase IIb study to compare the efficacy and safety of AZD9773 (CytoFab) with placebo...
News
Cipla launches the world’s first generic Pirfenidone in India
Cipla, among the world's leading generic pharmaceutical companies has introduced Pirfenidone in India; under the brand name Pirfenex, for the treatment of IPF. A chronic...
News
Sandoz announces launch of piperacillin and tazobactam for injection,...
Sandoz anounced the launch of piperacillin and tazobactam for injection, a generic equivalent of Zosyn®, in the US. Piperacillin and tazobactam for injection is an...
News
Bharat Biotech Announces Launched Indias First Cell-culture H1N1 Swine...
Bharat Biotech announced the launch of India?s first indigenously developed cell culture H1N1 swine fluvaccine under the brand name „HNVAC™. HNVAC™ is the only developing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.